| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
6.807 |
Evidence |
|
| RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
GIT2 |
IPI00238218 |
6.807 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
KCNIP3 |
KCNIP3, CSEN, DREAM, KCHIP3: Calsenilin |
6.807 |
Evidence |
|
| THOP1 |
THOP1: Thimet oligopeptidase |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
6.807 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
LRRC7 |
LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 |
6.807 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
HDAC2 |
HDAC2: Histone deacetylase 2 |
6.807 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
6.807 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
6.807 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
6.807 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
6.807 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
6.807 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
6.807 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
6.807 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
6.807 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
TIA1 |
TIA1: Nucleolysin TIA-1 isoform p40 |
6.807 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ACP1 |
ACP1: Low molecular weight phosphotyrosine protein phosphatase |
6.807 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
6.807 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
LRRC7 |
LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 |
6.807 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
6.807 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
6.807 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
SNX3 |
IPI00029740 |
6.807 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
MYO18A |
|
6.807 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
6.807 |
Evidence |
|
| MYBL2 |
MYBL2, BMYB: Myb-related protein B |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
6.807 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
6.807 |
Evidence |
|